Provided by Tiger Trade Technology Pte. Ltd.

Lifeward Ltd

6.50
+0.16002.52%
Post-market: 6.500.00000.00%19:30 EDT
Volume:3K
Turnover:18.83K
Market Cap:18.41M
PE:-0.38
High:6.50
Open:6.10
Low:6.10
Close:6.34
52wk High:10.13
52wk Low:4.14
Shares:2.83M
Float Shares:1.50M
Volume Ratio:0.34
T/O Rate:0.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-17.0029
EPS(LYR):-17.1600
ROE:-225.65%
ROA:-47.26%
PB:1.51
PE(LYR):-0.38

Loading ...

Lifeward Ltd Expected to Post a Loss of $1.34 a Share - Earnings Preview

Reuters
·
Aug 10

Lifeward to Report Q2 2026 Financial Results

Reuters
·
Aug 07

Lifeward Launches Pilot Program with Ottobock Care to Expand Access to ReWalk Personal Exoskeleton

Reuters
·
Aug 05

Nano Dimension Names Moshe Rozenbaum Interim CEO

Reuters
·
Jul 22

Lifeward Enters USD 5.58 Million Senior Secured Convertible Note Financing with Investors, Oramed Agent

Reuters
·
Jul 08

Press Release: Lifeward Secures Growth Capital to Accelerate Commercial Expansion with up to $11.2 Million in Strategic Financing

Dow Jones
·
Jul 08

Lifeward Q1 FY26 net loss widens to $10.79 million; revenue drops 22% to $3.92 million

Reuters
·
May 21

Lifeward files initial beneficial ownership statement for Chief Medical Officer Rose Keith Dale

Reuters
·
May 20

Lifeward names Keith D. Rose chief medical officer

Reuters
·
May 19

Press Release: Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform

Dow Jones
·
May 19

Lifeward Ltd reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 15

Lifeward delays Q1 10-Q filing, cites accounting work on strategic transaction

Reuters
·
May 15

Lifeward Q1 Adj. EPS $(3.13) Misses $(1.25) Estimate, Sales $3.923M Miss $5.775M Estimate

Benzinga Earnings
·
May 15

Lifeward Q1 FY26 net loss more than doubles to $10.8 million; revenue falls 22% to $3.9 million

Reuters
·
May 15

Press Release: Lifeward Reports First Quarter 2026 Financial Results

Dow Jones
·
May 15

Lifeward files initial beneficial ownership statement for Oramed Pharmaceuticals stake

Reuters
·
May 15

Lifeward Ltd expected to post a loss of $1.25 a share - Earnings Preview

Reuters
·
May 13

Lifeward Ltd expected to post a loss of $1.25 a share - Earnings Preview

Reuters
·
May 11

Lifeward to report first-quarter 2026 results, host earnings call

Reuters
·
May 11

Lifeward files to sell 7.26M ordinary shares for holders

TIPRANKS
·
Apr 28